August 2, 2021
2 mins read

India, UK to conduct clinical trials of Ashwagandha

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger…reports Asian Lite News.

The Ayush ministry’s All India Institute of Ayurveda in collaboration with the United Kingdom’s London School of Hygiene and Tropical Medicine will conduct a study on ‘Ashwagandha’ for promoting recovery from Covid-19 in a boost to the traditional Indian medicine system.

Both the institutions signed a Memorandum of Understanding to conduct the clinical trials of Ashwagandha on 2,000 people in three UK cities — Leicester, Birmingham, and London (Southall and Wembley), said the ministry in a statement.

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger.

It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in Covid, which is a multi-system disease with no evidence of its effective treatment or management.

The successful completion of the trial can be a major breakthrough and give scientific validity to India’s traditional medicinal system. While there have been several studies on Ashwagandha to understand its benefits in various ailments, this is the first time the Ministry has collaborated with a foreign institution to investigate its efficacy on Covid-19 patients.

AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator – International Projects, said that the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

The participants will have to take the 500mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events will be carried out.

“For three months, one group of 1,000 participants will be administered Ashwagandha (AG) tablets while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group’s treatment in a double-blind trial,” Dr Nesari said.

ALSO READ-World Hindu Economic Forum hosts Webinar on Ayurveda

READ MORE-Verstegen, Sri Sri Tattva join hands to offer sustainable agri solutions in Europe, UK

Previous Story

UK reports 24,470 Covid-19 cases, 65 deaths

Next Story

UK offers discounts on shopping, pizza for Covid shots

Previous Story

UK reports 24,470 Covid-19 cases, 65 deaths

Next Story

UK offers discounts on shopping, pizza for Covid shots

Latest from -Top News

Myanmar NUG Welcomes ICJ Ruling, Demands Rohingya Justice

Myanmar’s National Unity Government has welcomed the International Court of Justice’s judgment, describing it as an important step towards justice for the Rohingya…reports Asian Lite News Desk Myanmar’s National Unity Government (NUG)

Tulip Siddiq Weighs Legal Action Against Yunus

British MP Tulip Siddiq is considering legal action against former Bangladesh interim leader Muhammad Yunus over corruption allegations that led to her resignation..reports Asian Lite News Desk British MP Tulip Siddiq is
Go toTop

Don't Miss

Anderson dethrones Cummins to become top bowler

Anderson is the oldest bowler to hold the top ranking

Race for Cong top post hots up

Tharoor says he is open to the idea of a